Collaborative Drug Discovery Partners with Eli Lilly to Integrate AI/ML Models into CDD Vault Platform
核心洞察
Collaborative Drug Discovery (搜索) announced an agreement with Eli Lilly to integrate Lilly TuneLab (搜索) AI/ML models into the CDD Vault (搜索) platform for biotech companies.
Lilly TuneLab (搜索) provides access to predictive models trained on decades of Lilly's proprietary research data to accelerate biotech innovation.
The integration will enable biotech companies using CDD Vault (搜索) to utilize select Lilly ADMET (搜索) models within their natural scientific workflows.
Collaborative Drug Discovery (搜索) (CDD), a leading provider of data management solutions for the pharmaceutical and biotechnology industries, announced an agreement with Eli Lilly and Company to integrate Lilly TuneLab (搜索) into CDD Vault (搜索). The partnership will make Lilly's AI/ML drug discovery models available to biotech companies through CDD's platform.
Strategic Integration of AI/ML Models
Lilly TuneLab (搜索) was created by Lilly to accelerate biotech innovation by enabling participating companies to access models trained on decades of Lilly's proprietary research data. Through this agreement, biotech companies that use CDD Vault (搜索) will be able to utilize select Lilly predictive models within their natural scientific workflows.
"By integrating TuneLab directly into CDD Vault (搜索), we are advancing CDD's core vision to enable collaboration across drug discovery teams and organizations," said Barry A. Bunin, CDD Chief Executive Officer and President. "We believe that solving the most complex challenges in drug discovery will depend on innovative collaboration models that provide broad access to research data and empower chemists and biologists to make informed, data-driven decisions."
Technical Implementation and Workflow Integration
The agreement paves the way for the planned integration of Lilly TuneLab (搜索) in both the core and AI modules within CDD Vault (搜索) for biotech companies that opt in to the program. Bunin emphasized that "TuneLab's ADMET (搜索) models will fit in our trusted secure CDD Vault software environment in natural workflows for experimental and computational scientists and with our growing CDD Vault ecosystem of biopharmaceutical companies."
Dr. Peter Gedeck, CDD Research Informatics Senior Scientist, highlighted the synergistic potential of the integration: "TuneLab's models are synergistic with our innovations such as Zero Click Models, Generative Bioisosteres, as well as Ultrafast Deep Learning similarity to SureChEMBL for novelty and Enamine libraries for convenient SAR-by-catalog."
Platform Capabilities and Vision
This agreement builds on CDD's founding vision from 2004 to demonstrate the economics of efficiency of web-based collaboration. CDD Vault (搜索) serves as a premier hosted database solution for the secure management and sharing of biological and chemical research data, providing tools for chemical and biological registration management, structure-activity relationships (SAR), and experiment organization.
The platform's available modules include Registration, Activity & Visualization, Assays, ELN, Inventory, Curves, AI, and Automation, creating a comprehensive ecosystem for pharmaceutical research and development activities.